Results 21 - 30 of 2718 : Previous 1 2 3 4 5 6 7 8 9 Next
Will the Dogs of the Dow Beat the Market?
A weekly performance review of the Dogs of the Dow.
These Dow Stocks May Never Grow Again
Even analysts are pessimistic about the prospects for these stocks.
The Dow's Biggest Losers Today
Only a few blue chips took a dive as the Dow rejoiced over a Fed announcement.
Johnson & Johnson returns to growth.
Cash is king. What a company does with it matters.
In a battle of risk vs. reward, let's see which one comes out on top.
Taking a look at some of the most popular blue chips.
Check out the cash king margin.
19 Clinical Trials Aren't Enough
The FDA rejects Bristol-Myers and AstraZeneca's dapagliflozin.
No Vacancy: Workers Need Not Apply to This Sector
Pharmaceutical and biotech layoffs are kicking into high gear.